What’s The Key Support Level On Cyclerion Therapeutics, Inc. (CYCN)?

Cyclerion Therapeutics, Inc. (CYCN) has seen some recent activity in the market and its stock finished trading at $2.2500 yesterday. People are starting to take interest of CYCN as the stock traded as high as $2.4484 and as low as $2.2500 in the last market trading session.

Cyclerion Therapeutics, Inc. (CYCN) average trading volume is 511.54K. However, in the last market trading session Cyclerion Therapeutics, Inc. (CYCN) exchanged 1,124,452 shares. First upside resistance level on CYCN is $8.39. CYCN 50-day moving average is $5.7033 and CYCN 200-day moving average is $5.0051.

Cyclerion Therapeutics, Inc. (CYCN) recent performance has been shown by the recent movement in CYCN stock. CYCN has performed -67.34% over the past 4 weeks, CYCN has performed -44.44% over the past 3 months and CYCN has shown -83.25% over the past 12 months. Cyclerion Therapeutics, Inc. (CYCN) has a 52 week range of $1.6900 to $8.9600. Cyclerion Therapeutics, Inc. (CYCN) is trading 33.14% from its 52 week low and -84.77% from its 52 week high. Cyclerion Therapeutics, Inc. (CYCN) is showing a 3.66% short float showing the quantity short in the float.

CYCN has 27.79M shares outstanding and 25.61M shares in the float. Cyclerion Therapeutics, Inc. (CYCN) currently has a market cap of $78.08M and income of -93.10M. The EPS next quarter for CYCN is -0.56 and forecasted EPS next year is 67.90%. The market cap of Cyclerion Therapeutics, Inc. (CYCN) at $78.08M represents how many People own shares of CYCN and is calculated off the last price ($2.2500) of CYCN and the quantity of shares outstanding (27.79M) with Cyclerion Therapeutics, Inc. (CYCN).

Cyclerion Therapeutics, Inc. (CYCN) has aggregate cash (mrq) of 56.46M, aggregate cash per share (mrq) of 1.66, aggregate debt of CYCN rests at 52.59M and aggregate debt/equity (mrq) is 79.56. . Cyclerion Therapeutics, Inc. (CYCN) operational cash flow (ttm) is -89.38M, CYCN leveraged free cash flow (ttm) is -50.31M.

CYCN is trading -51.77% below (bearish) its SMA20, -62.37% below (bearish) its SMA50 and -50.75% below (bearish) its SMA200.

Related Articles

Zebra (NASDAQ: ZBRA) And XMReality Inks Partnership Agreement

Zebra Technologies Corporation (NASDAQ: ZBRA) and XMReality publicized that the two have signed an agreement to work together and collaborate on ideas that offer...

Elanco (NYSE: ELAN) Launch Public Offering Of Common Stock

Elanco Animal Health Inc. (NYSE: ELAN) shares that it is planning to commence the public offering of 54,500,000 shares of common stock. It will...

Jacobs (NYSE: J) Partners with PA Consulting

Jacobs Engineering Group, Inc. (NYSE: J), a famous construction company announced that it will be collaborating with PA Consulting. The firm has purchased an...

Get in Touch

19,000FansLike
35,222FollowersFollow
22,458FollowersFollow

Latest Posts

Zebra (NASDAQ: ZBRA) And XMReality Inks Partnership Agreement

Zebra Technologies Corporation (NASDAQ: ZBRA) and XMReality publicized that the two have signed an agreement to work together and collaborate on ideas that offer...

Elanco (NYSE: ELAN) Launch Public Offering Of Common Stock

Elanco Animal Health Inc. (NYSE: ELAN) shares that it is planning to commence the public offering of 54,500,000 shares of common stock. It will...

Jacobs (NYSE: J) Partners with PA Consulting

Jacobs Engineering Group, Inc. (NYSE: J), a famous construction company announced that it will be collaborating with PA Consulting. The firm has purchased an...

Fuwei (NASDAQ: FFHL) Plans To Sell Dornier Production Line

Fuwei Films (Holdings) Co., Ltd. (NASDAQ: FFHL) recently declared that it will be closing its Dornier line of production as early as possible. Fuwei...

PPG Industries (NYSE: PPG) Announces Accquisition Of Ennis-Flint

PPG Industries, Inc. (NYSE: PPG) is planning to buy Ennis-Flint in a deal valued at nearly $1.15 billion. The decision to acquire Ennis-Flint will...